A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer
Clinical trial NCT02684032 · COMPLETED
Trial details
- NCT number
- NCT02684032
- Sponsor
- Celcuity Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-14
- Primary completion
- 2022-01-19
- Enrollment
- 141
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.